DiviDrip · TVRD

TVRD — Tvardi Therapeutics, Inc.

TVRD is Tvardi Therapeutics, Inc. (Healthcare) — a non-dividend-paying stock. Trading at $1.91. Market cap: $25M. Capital Quality Rank: 11/100 — Systemic risk.

Stock snapshot

Price$1.91
Market cap$25M
SectorHealthcare
ExchangeNCM
Pays dividendNo

Capital Quality & fundamentals

DiviDrip's Capital Analytics engine ranks every non-dividend stock 1-100 on a 4-factor composite (Shareholder Yield 30%, Cash-Flow ROI 25%, Operating Momentum 25%, Tail-Risk 20%) — sector-neutralized so a biotech isn't penalized for negative earnings the way a utility would be.

Capital Quality Rank (1-100)11 / 100 · Systemic risk
ROIC (TTM)-3255.8%
Altman Z-score zoneDistress

About TVRD

Tvardi Therapeutics Inca clinical-stage biopharmaceutical company focused on the development of novel, oral, small molecule therapies targeting Signal Transducer and Activator of Transcription 3 (STAT3) to treat inflammatory and proliferative diseases with unmet need. Its pipeline includes two oral, small molecule STAT3 inhibitors: TTI-101 and TTI-109. TTI-101 is its first-generation direct STAT3 inhibitor, currently in Phase 1b/2 clinical development in hepatocellular carcinoma (HCC). TTI-109 is a phosphate prodrug of TTI-101 that is mechanistically identical to its parent molecule but is designed to enhance its ability to target STAT3.

Listed2025Employees12HQSugar Land, TXSectorHealthcareWebsitetvarditherapeutics.com

Related non-dividend companies

Other non-dividend stocks investors research alongside TVRD. Peer set from Massive news + returns similarity, filtered to names we currently track.

Frequently asked

What is TVRD's current stock price?

TVRD (Tvardi Therapeutics, Inc.) is currently trading at $1.91.

Does TVRD pay a dividend?

TVRD (Tvardi Therapeutics, Inc.) does not currently pay a regular dividend.

What is TVRD's Capital Quality Rank?

TVRD has a Capital Quality Rank of 11/100 — Systemic risk. This score blends ROIC, revenue growth, buybacks, and balance-sheet health.

Track TVRD in DiviDrip

Add TVRD to your watchlist on DiviDrip to monitor price, fundamentals, and Capital Quality Rank week-over-week. Built for long-term investors tracking both dividend and non-dividend names.

Data refreshed 2026-09-07. Not investment advice. Prices change continuously; always verify the latest numbers in the live app before buying.

Related guides

DiviDrip is a free dividend portfolio tracker built by dividend investors, for dividend investors. Try it free — no payment, no upsell, ever. Read the How-To to see how each tool fits together, or browse the Glossary for every term defined plain-English.

Disclaimer: The information provided on this website/service is for informational purposes only and does not constitute financial, investment, or legal advice. Investing in stocks involves high risk, including the loss of principal. We are not responsible for any financial losses or damages resulting from your reliance on this data. Always consult with a qualified financial professional before making investment decisions.

Trademark Notice: Twylight Crow's Dividend Tracker (formerly indexed as DiviDrip) is an independent portfolio utility. This tool is not affiliated with, authorized, endorsed by, or in any way officially connected to Dividrip.com or its international affiliates.

Contact: dividrip@twylightcrow.com© 2026 Twylight Crow